DC1009Laropiprant
Laropiprant is a DP1 receptor antagonist for prostanoid signaling and platelet-function research. Its effects on platelet activation vary with agonist and concentration.
View activity & pricesSmall Molecule Research ToolsDC1009 
DC10134
DC10727
DC11043
DC11524
DC11526
DC12020
DC12287
DC12438
Cardiovascular & Metabolic Research
9 research products
DC1009DC10134Obicetrapib (AMG-899,TA-8995)
Obicetrapib, also known as TA-8995, is a CETP inhibitor for lipoprotein metabolism and cholesterol-efflux research.
View activity & pricesDC10727Elafibranor(GFT505)
Elafibranor (GFT505) is a dual PPARα/δ agonist used in hepatic lipid metabolism, inflammation and fibrosis research.
View activity & pricesDC11043Omidenepag
Omidenepag is an EP2 receptor agonist for prostanoid signaling and ocular-cell research.
View activity & pricesDC11524Mavacamten (MYK-461)
Mavacamten (MYK-461) is a cardiac myosin inhibitor used to study sarcomere contractility and hypertrophic cardiomyopathy.
View activity & pricesDC11526Praliciguat
Praliciguat is an sGC stimulator for nitric-oxide/cGMP signaling, renal inflammation and fibrosis research.
View activity & pricesDC12020MK-8722
MK-8722 is a direct allosteric activator of mammalian AMPK complexes for metabolic signaling and glucose-homeostasis research.
View activity & pricesDC12287delta-Valerobetaine
Delta-valerobetaine is a microbiome-derived metabolite used to investigate mitochondrial fatty-acid oxidation and diet-dependent obesity.
View activity & pricesDC12438G6PD activator AG1
AG1 is a small-molecule G6PD activator for enzyme oligomerization, NADPH metabolism and redox research.
View activity & pricesLaropiprantFeatured
100 mg US$650 · 250 mg US$1,100 · 1 g US$2,400 · 10 mM * 1 mL in DMSO US$150Laropiprant is a DP1 receptor antagonist for prostanoid signaling and platelet-function research. Its effects on platelet activation vary with agonist and concentration.
Obicetrapib (AMG-899,TA-8995)Featured
1g US$2,600 · 100mg US$750 · 250mg US$1,200Obicetrapib, also known as TA-8995, is a CETP inhibitor for lipoprotein metabolism and cholesterol-efflux research.
Elafibranor(GFT505)Featured
100 mg US$550 · 250 mg US$750 · 1 g US$1,350 · 10 mM * 1 mL in DMSO US$220Elafibranor (GFT505) is a dual PPARα/δ agonist used in hepatic lipid metabolism, inflammation and fibrosis research.
OmidenepagFeatured
1g US$3,500 · 250 mg US$1,800 · 100 mg US$990 · 10 mM * 1 mL in DMSO US$220Omidenepag is an EP2 receptor agonist for prostanoid signaling and ocular-cell research.
Mavacamten (MYK-461)Featured
100 mg US$550 · 250 mg US$900 · 1 g US$1,800 · 10 mM * 1 mL in DMSO US$220Mavacamten (MYK-461) is a cardiac myosin inhibitor used to study sarcomere contractility and hypertrophic cardiomyopathy.
PraliciguatFeatured
100 mg US$900 · 250 mg US$1,600 · 1 g US$3,300 · 10 mM * 1 mL in DMSO US$220Praliciguat is an sGC stimulator for nitric-oxide/cGMP signaling, renal inflammation and fibrosis research.
MK-8722Featured
100 mg US$850 · 250 mg US$1,350 · 1 g US$2,700 · 10 mM * 1 mL in DMSO US$220MK-8722 is a direct allosteric activator of mammalian AMPK complexes for metabolic signaling and glucose-homeostasis research.
delta-ValerobetaineFeatured
100 mg US$700 · 250 mg US$1,200 · 1 g US$2,500 · 10 mM * 1 mL in DMSO US$220Delta-valerobetaine is a microbiome-derived metabolite used to investigate mitochondrial fatty-acid oxidation and diet-dependent obesity.
G6PD activator AG1Featured
10mg US$550 · 25mg US$950 · 100mg US$1,650AG1 is a small-molecule G6PD activator for enzyme oligomerization, NADPH metabolism and redox research.